News

The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.…  Read more

Chairman of the Hudson Institute of Medical Research Board, Dr Bob Edgar is delighted to announce the appointment of The Hon. Jill Hennessy as a new non-Executive Director of the Board of Hudson Institute.…  Read more

Congratulations to Professor Ron Firestein, who was announced this week as Deputy Director of Hudson Institute of Medical Research.…  Read more

It’s a disease in search of a remedy, but Hudson Institute researchers have identified a new pancreatitis treatment target, giving hope to sufferers worldwide.…  Read more

If you see your doctor on the phone in the labour ward, don’t panic, because a new emergency clinical trial app is helping them to save time and save lives.…  Read more

Two new candidates have been identified as crucial factors in maintaining good intestinal health.…  Read more

People living with pelvic organ prolapse (POP) have had a limited number of treatments available to them over the years, so a new POP treatment option can be a cause for excitement.…  Read more

It’s a condition that is rarely spoken about, but one Australian woman has set out to change that – meet Hudson Institute’s new pelvic organ prolapse (POP) advocate, Sally Maconochie.…  Read more

Hudson Institute researchers have featured prominently among the latest recipients of NHMRC Ideas Grants.…  Read more

They’ve already identified a major undiagnosed cause of hypertension (high blood pressure), now the same team of researchers is helping doctors to better assess hypertension risk.…  Read more